Administration methods and dosage of poly(lactic acid)-glycol intervention to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalitis mice
Abstract Background Myelin oligodendrocyte glycoprotein-associated disorders (MOGAD) is an autoimmune central nervous system disease. Antigen-specific immune tolerance using nanoparticles such as Polylactic-co-glycolic acid (PLGA) have recently been used as a new therapeutic tolerization approach fo...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2024-03-01
|
| Серія: | BMC Neuroscience |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12868-024-00859-y |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|